Dark

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ

At Close

Dec 12, 2025 3:59:30 PM EST

0.8818USD-0.927%(-0.0083)152,250

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Dec 12, 2025 8:25:30 AM EST

0.9200USD+3.371%(+0.0300)100

After-hours

Dec 11, 2025 4:36:30 PM EST

0.9296USD+5.769%(+0.0507)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

26.19M

Industry

Biotechnology

Next Earnings

Dec 17, 2025 (4d)

NRSN Stats

Avg. Vol. 10 Day

397,982

Avg. Vol. 30 Day

386,911

Employees

Market Cap

26,187,375

Shares Out.

29,699,319

On/Off Exchange

36%/64%

6 Month Beta

1.98

1 Year Beta

0.47

2 Year Beta

0.61

3 Year Beta

0.46

52 Week Low

0.81

52 Week High

2.60

SMA50

1.10

SMA200

1.33

1 Week

-24.64%

1 Month

-3.90%

3 Month

-27.73%

6 Month

-62.95%

1 Year

+2.53%

2 Year

+29.67%

5 Year

-78.18%

Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $0.8818, and today's volume is 152,250. NRSN is down -0.927% today. The 30 day average volume is 386,911. NRSN market cap is 26.19M with 29,699,319 shares outstanding.

.dark-mode .Kjsg44{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Kjsg44{ color: #333333; background-color: white; border: 2px solid #333333; }NRSNNeuroSense Therapeutics Ltd.stock NASDAQ

NRSN Stock Summary

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ